“…Perfusion presents a number of advantages over other modes of cultivation including increased volumetric productivity, reduced labor and costs, and rapid removal of easily inactivated products from the culture environment (Prior et al, 1989). However, although high density cultures of hybridoma or recombinant myeloma cells can be achieved, decreasing viabilities are observed in a number of different perfusion systems (Al-Rubeai et al, 1992;Avgerinos et al, 1990;Banik and Heath, 1994;de la Broise et al, 1991de la Broise et al, , 1992Hansen et al, 1993;Hiller et al, 1993;Johnson et al, 1996;Kitano et al, 1986;Mercille et al, 1994c;Reuveny et al, 1986;Schmid et al, 1992;Tokashiki and Takamatsu, 1993;Trampler et al, 1994;Van Erp et al, 1991). Under these conditions, an equilibrium is established in which a significant loss of cell viability is matched by a high level of proliferation, leading to a significant waste of metabolic energy that could be more appropriately diverted to recombinant protein production (de la Broise et al, 1991).…”